» Articles » PMID: 11311841

Psychological Response to Prenatal Genetic Counseling and Amniocentesis

Overview
Publisher Elsevier
Specialties Health Services
Nursing
Date 2001 Apr 20
PMID 11311841
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of the present study was to characterize the psychological status (attitudes toward selective abortion, perceived risk, comprehension, patient satisfaction, coping, and state anxiety) of pregnant women at increased risk for fetal genetic anomalies who were referred for prenatal genetic counseling and amniocentesis; to determine which of these factors would predict amniocentesis use; and to identify patient outcomes associated with counseling and testing. Participants were 129 women aged 18 years and older who had one or more fetal genetic risk factors. All were recruited from an urban women's health clinic. The results revealed elevated perceptions of risk and moderate state anxiety despite adequate comprehension of, and patient satisfaction with, the process and content of genetic counseling. Approximately 78% agreed to testing; those who consented were more likely to hold favorable attitudes toward abortion than those who refused. Post-counseling, women experienced decrease in their perceived risk of having a baby born with a birth defect although perceived risk estimates remained higher than actual risks. Anxiety was clinically elevated and highest at the pre-counseling stage, though it dissipated to normal levels over time. Previous experience with prenatal diagnostic testing, increased perceived risk of a birth anomaly, and favorable attitudes toward abortion were independently associated with increased pre-counseling anxiety. Women who were more anxious pre-counseling remained more anxious post-counseling. Coping (high versus low monitoring) was unrelated to anxiety. These findings suggest that women who participate in prenatal counseling and testing may be subject to experience distress and unrealistic perceptions of their risk and may benefit from interventions designed to lessen these states.

Citing Articles

Prenatal diagnosis following preimplantation genetic testing for monogenic conditions: a single centre record linkage study.

Poulton A, Menezes M, Hardy T, Lewis S, Hui L J Assist Reprod Genet. 2025; 42(1):275-284.

PMID: 39853687 PMC: 11805740. DOI: 10.1007/s10815-024-03346-9.


Women's experiences with non-invasive prenatal testing in Switzerland: a qualitative analysis.

Tyebally Fang M, Germani F, Spitale G, Wascher S, Kunz L, Biller-Andorno N BMC Med Ethics. 2023; 24(1):85.

PMID: 37872496 PMC: 10594794. DOI: 10.1186/s12910-023-00964-3.


Decision-making process about prenatal genetic screening: how deeply do moms-to-be want to know from Non-Invasive Prenatal Testing?.

Oliveri S, Ongaro G, Cutica I, Menicucci G, Belperio D, Spinella F BMC Pregnancy Childbirth. 2023; 23(1):38.

PMID: 36653738 PMC: 9845820. DOI: 10.1186/s12884-022-05272-z.


Psychometric of Physicians' Awareness, Attitudes and Performance Questionnaire about Genetic Counseling and Testing.

Mousavinasab S, Khosravi S, Ramezanzadeh M Int J Prev Med. 2022; 13:134.

PMID: 36452475 PMC: 9704477. DOI: 10.4103/ijpvm.IJPVM_608_20.


OnkoRiskNET: a multicenter, interdisciplinary, telemedicine-based model to improve care for patients with a genetic tumor risk syndrome.

Tecklenburg J, Vajen B, Morlot S, Anders P, Memenga P, Link E BMC Health Serv Res. 2022; 22(1):805.

PMID: 35729592 PMC: 9210737. DOI: 10.1186/s12913-022-08172-2.